Cook Medical: Transseptal Needle and Transseptal Needle Catheter — FDA announcement Oct 19, 2021

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Oct 19, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Transseptal Needle and Transseptal Needle Catheter
Reason
Complaints of rust on the products
Classification
Not supplied
Recalling firm
Cook Medical
Quantity
Not supplied
Agency-reported status
Terminated in FDA listing
Source record identifier
b266f516639de15f

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityPRODUCT BRAND NAME | INTENDED USE | REFERENCE PART NUMBER (RPN) | ORDER NUMBER (GPN) | LOT NUMBER / UDI | RANGE OF MANUFACTURE DATES FOR AFFECTED PRODUCTS; Transseptal Needle | Intended for transseptal left heart access in both diagnostic and interventional procedures | TSNC-18-71.0 | G02364 | All | October 02, 2016 through July 22, 2021; TSNC-19-56.0 | G02365; Transseptal Needle with Catheter | Intended to facilitate transseptal entry into the left atrium | TSN-17-75.0-ENDRYS | G19261

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
PRODUCT BRAND NAME INTENDED USE REFERENCE PART NUMBER (RPN) ORDER NUMBER (GPN) LOT NUMBER / UDI RANGE OF MANUFACTURE DATES FOR AFFECTED PRODUCTS
Transseptal Needle Intended for transseptal left heart access in both diagnostic and interventional procedures TSNC-18-71.0 G02364 All October 02, 2016 through July 22, 2021
TSNC-19-56.0 G02365
Transseptal Needle with Catheter Intended to facilitate transseptal entry into the left atrium TSN-17-75.0-ENDRYS G19261

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date
Oct 19, 2021
Company announcement date
Oct 18, 2021

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records